Yang H, Kuhn C, Kolben T, et al
GLP-1Ra GLP-1Ra were first marketed for the treatment of T2D (at a lower dose and as daily SC injections), then as weekly injections and finally, at larger doses for the treatment of obesity
Providers on the Mochi network conduct behavioral assessment, review medication interactions, and establish baseline metabolic markers before initiating compounded GLP-1 therapy
Store in a dry place at room temperature (15 25 C), protect from direct sunlight
Another study assessed 524, 510, and 40 spontaneous reports of pancreatitis from the FDA Adverse Event Reporting System (FAERS) database, VigiBase, and CARD databases, respectively, to determine the potential association between SGLT2 inhibitors and pancreatitis